08:00 , Nov 3, 2014 |  BioCentury  |  Finance

Metallic strategy

Viamet Pharmaceuticals Inc. 's decision to do a $60 million series D round one day after withdrawing its planned $75 million IPO late last month can be explained by a "choppy" IPO market and a...
07:00 , Oct 27, 2014 |  BC Week In Review  |  Company News

Viamet board of directors update

Viamet Pharmaceuticals Inc. , Durham, N.C.   Business: Infectious, Cancer   Appointed: Adrian Howd, partner at Brandon Point Industries Ltd.; Robert Ingram as chairman, partner at Hatteras Venture Partners; and Kelly Martin, co-founder of Brandon...
07:00 , Oct 27, 2014 |  BC Week In Review  |  Financial News

Viamet completes venture financing

Viamet Pharmaceuticals Inc. , Durham, N.C.   Business: Infectious, Cancer   Date completed: 2014-10-21   Type: Venture financing   Raised: $60 million   Investors: Brandon Point Industries; Woodford Investment Management  ...
03:53 , Oct 22, 2014 |  BC Extra  |  Financial News

Viamet replaces IPO with $60M D round

One day after withdrawing a proposed IPO, Viamet Pharmaceuticals Inc. (Durham, N.C.) closed a $60 million series D round led by new investor Brandon Point Industries Ltd. working with Woodford Investment Management. The company did...